000			02307 a2200661 4500
005			20250517022339.0
264		0	_c20150807
008			201508s 0 0 eng d
022			_a2326-5205
024	7		_a10.1002/art.39104 _2doi
040			_aNLM _beng _cNLM
100	1		_aMiloslavsky, E M
245	0	0	_aOutcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids. _h[electronic resource]
260			_bArthritis & rheumatology (Hoboken, N.J.) _cJun 2015
300			_a1629-36 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis _xdrug therapy
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use
650	0	4	_aAutoantibodies _ximmunology
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aGranulomatosis with Polyangiitis _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMaintenance Chemotherapy
650	0	4	_aMale
650	0	4	_aMicroscopic Polyangiitis _xdrug therapy
650	0	4	_aMyeloblastin _ximmunology
650	0	4	_aPeroxidase _ximmunology
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aRituximab
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aSpecks, U
700	1		_aMerkel, P A
700	1		_aSeo, P
700	1		_aSpiera, R
700	1		_aLangford, C A
700	1		_aHoffman, G S
700	1		_aKallenberg, C G M
700	1		_aSt Clair, E W
700	1		_aTchao, N K
700	1		_aDing, L
700	1		_aIklé, D
700	1		_aVillareal, M
700	1		_aLim, N
700	1		_aBrunetta, P
700	1		_aFervenza, F C
700	1		_aMonach, P A
700	1		_aStone, J H
773	0		_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 67 _gno. 6 _gp. 1629-36
856	4	0	_uhttps://doi.org/10.1002/art.39104 _zAvailable from publisher's website
999			_c24713207 _d24713207